Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review.

Crohn’s disease joints ulcerative colitis

Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
05 Jun 2024
Historique:
received: 13 01 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: aheadofprint

Résumé

Inflammatory bowel disease (IBD)-associated peripheral spondyloarthritis (pSpA) decreases quality of life and remains poorly understood. Given the prevalence of this condition and its negative impact, it is surprising that evidence-based disease definitions and diagnostic strategies are lacking. This systematic review summarizes available data to facilitate development and validation of diagnostics, patient-reported outcomes, and imaging indices specific to this condition. A literature search was conducted. Consensus or classification criteria, case series, cross-sectional studies, cohort studies, and randomized controlled trials related to diagnosis were included. A total of 44 studies reporting data on approximately 1500 patients with pSpA were eligible for analysis. Data quality across studies was only graded as fair to good. Due to large heterogeneity, meta-analysis was not possible. The majority of studies incorporated patient-reported outcomes and a physical examination. A total of 13 studies proposed or validated screening tools, consensus, classification, or consensus criteria. A total of 28 studies assessed the role of laboratory tests, none of which were considered sufficiently accurate for use in diagnosis. A total of 17 studies assessed the role of imaging, with the available literature insufficient to fully endorse any imaging modality as a robust diagnostic tool. This review highlights existing inconsistency and lack of a clear diagnostic approach for IBD-associated pSpA. Given the absence of an evidence-based approach, a combination of existing criteria and physician assessment should be utilized. To address this issue comprehensively, our future efforts will be directed toward pursuit of a multidisciplinary approach aimed at standardizing evaluation and diagnosis of IBD-associated pSpA. This systematic review highlights the lack of an evidence-based approach to the diagnosis of inflammatory bowel disease–associated peripheral spondyloarthritis and the need to standardize evaluation and diagnosis via multidisciplinary collaboration with development of patient-reported outcomes and imaging indices.

Sections du résumé

BACKGROUND BACKGROUND
Inflammatory bowel disease (IBD)-associated peripheral spondyloarthritis (pSpA) decreases quality of life and remains poorly understood. Given the prevalence of this condition and its negative impact, it is surprising that evidence-based disease definitions and diagnostic strategies are lacking. This systematic review summarizes available data to facilitate development and validation of diagnostics, patient-reported outcomes, and imaging indices specific to this condition.
METHODS METHODS
A literature search was conducted. Consensus or classification criteria, case series, cross-sectional studies, cohort studies, and randomized controlled trials related to diagnosis were included.
RESULTS RESULTS
A total of 44 studies reporting data on approximately 1500 patients with pSpA were eligible for analysis. Data quality across studies was only graded as fair to good. Due to large heterogeneity, meta-analysis was not possible. The majority of studies incorporated patient-reported outcomes and a physical examination. A total of 13 studies proposed or validated screening tools, consensus, classification, or consensus criteria. A total of 28 studies assessed the role of laboratory tests, none of which were considered sufficiently accurate for use in diagnosis. A total of 17 studies assessed the role of imaging, with the available literature insufficient to fully endorse any imaging modality as a robust diagnostic tool.
CONCLUSIONS CONCLUSIONS
This review highlights existing inconsistency and lack of a clear diagnostic approach for IBD-associated pSpA. Given the absence of an evidence-based approach, a combination of existing criteria and physician assessment should be utilized. To address this issue comprehensively, our future efforts will be directed toward pursuit of a multidisciplinary approach aimed at standardizing evaluation and diagnosis of IBD-associated pSpA.
This systematic review highlights the lack of an evidence-based approach to the diagnosis of inflammatory bowel disease–associated peripheral spondyloarthritis and the need to standardize evaluation and diagnosis via multidisciplinary collaboration with development of patient-reported outcomes and imaging indices.

Autres résumés

Type: plain-language-summary (eng)
This systematic review highlights the lack of an evidence-based approach to the diagnosis of inflammatory bowel disease–associated peripheral spondyloarthritis and the need to standardize evaluation and diagnosis via multidisciplinary collaboration with development of patient-reported outcomes and imaging indices.

Identifiants

pubmed: 38836521
pii: 7688049
doi: 10.1093/ibd/izae114
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Katherine Falloon (K)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland OH, USA.

Zahra Dossaji (Z)

Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV, USA.

Pooja Mude (P)

Department of Gastroenterology, Ascension Providence, Southfield, MI, USA.

Suha Abushamma (S)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland OH, USA.

Ashwin Ananthakrishnan (A)

Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.

Edward L Barnes (EL)

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA.

Jaideep Bhalla (J)

Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Abhik Bhattacharya (A)

Department of Gastroenterology, Mount Sinai Hospital, New York, NY, USA.

Shashank Cheemalavagu (S)

Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA.

Jean-Fred Colombel (JF)

Department of Gastroenterology, Mount Sinai Hospital, New York, NY, USA.

Raymond K Cross (RK)

Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Joerg Ermann (J)

Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Christina Ha (C)

Department of Gastroenterology, Mayo Clinic Arizona, Scottsdale, AZ, USA.

Hans Herfarth (H)

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA.

Sara Horst (S)

Department of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, TN, USA.

Jason Hou (J)

Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey Veterans Affairs Medical Center and Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX, USA.

M Elaine Husni (ME)

Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA.

Theresa M Kline (TM)

Cleveland Clinic Foundation, Cleveland Clinic Library, Cleveland, OH, USA.

Kristine A Kuhn (KA)

Division of Rheumatology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Millie D Long (MD)

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA.

Edward V Loftus (EV)

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.

Dana J Lukin (DJ)

Department of Gastroenterology and Hepatology, Weill Cornell Medical Center, NY, NY, USA.

Aditi Patel (A)

Department of Rheumatologic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA.

David T Rubin (DT)

Department of Gastroenterology, Hepatology, and Nutrition, University of Chicago, Chicago, IL, USA.

Ellen J Scherl (EJ)

Department of Gastroenterology and Hepatology, Weill Cornell Medical Center, NY, NY, USA.

Samir A Shah (SA)

Department of Gastroenterology, Brown University, Providence, RI, USA.

Bernadette C Siaton (BC)

Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.

Joseph Sleiman (J)

Department of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Taha Qazi (T)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland OH, USA.

Michael H Weisman (MH)

Department of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.

Benjamin L Cohen (BL)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland OH, USA.

Brian G Feagan (BG)

Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada.
Alimentiv Inc., London, ON, Canada.

Florian Rieder (F)

Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland OH, USA.
Cleveland Clinic Program for Global Translational Inflammatory Bowel Disease, Cleveland Clinic, OH, USA.
Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, OH, USA.

Classifications MeSH